GUILDFORD, England, Oct. 14, 2026 Ergomed Group Appoints Jovan Willford as Chief Executive Officer Experienced executive across life sciences data and technology-enabled healthcare to lead Ergomed's next phase of growth across CRO, pharmacovigilance and consulting....
ADAMAS Consulting is proud to be a Platinum sponsor at RQA 8th Global QA Conference 2026.
As a trusted quality and compliance partner to life sciences organizations, we help pharmaceutical, biotechnology, and medical device companies strengthen GxP quality systems, maintain inspection readiness, and navigate evolving regulatory expectations with confidence. Visit us to connect with our experts and discuss practical solutions for clinical quality assurance, compliance, auditing, AI governance, and operational excellence.
Clinical Quality is moving upstream. Explore key insights from senior Quality leaders on proactive risk management, vendor oversight, data-enabled QA and the evolving role of Quality as a strategic partner.
Explore what the FDA’s Real-Time Clinical Trials initiative means for sponsors and why risk-based, data-enabled QA oversight is becoming essential under ICH E6 (R3).
Planning to attend SCOPE Summit Europe 2026? Schedule time with our team in advance to discuss your clinical quality, compliance, and regulatory priorities, and explore how ADAMAS Consulting can help accelerate your development programs while maintaining the highest standards of quality and regulatory excellence.
As pharmacovigilance systems continue to evolve, audit planning must evolve with them.
ADAMAS Consulting will attend a series of upcoming Clinical Quality Roundtable events in the United States.
Join ADAMAS Consulting and Cyntegrity for an expert-led webinar on how to build practical, risk-based QA oversight strategies under ICH E6 (R3).
ADAMAS Consulting is proud to exhibit at SQA Annual Meeting 2026 as a Platinum Sponsor.
How ICH E6 R3 is reshaping clinical trial oversight through risk-based approaches, Quality by Design, and stronger data governance.
Ergomed Group announces the appointment of Jovan Willford as CEO. Start date November 2nd.
RQA 8th Global QA Conference 2026 | London, UK
From Reactive Compliance to Strategic Partnership: How Clinical Quality Is Evolving
FDA’s Real-Time Clinical Trial Initiative: Endorses Data-Enabled QA Oversight
SCOPE Europe 2026 | Barcelona, Spain